<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>cardiovascular medicine</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>cardiovascular medicine | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification
Authors: Climente-Gonzalez, H.; Oh, M.; Chajewska, U.; Hosseini, R.; Mukherjee, S.; Gan, W.; Traylor, M.; Hu, S.; Fatemifar, G.; Del Villar, P. P.; Vernet, E.; Koelling, N.; Du, L.; Abraham, R.; Li, C.; Howson, J. M. M.
Score: 6.5, Published: 2024-01-13 DOI: 10.1101/2024.01.12.24301213
Cardiovascular diseases (CVD), primarily coronary heart disease and stroke, rank amongst the leading causes of long-term disability and mortality.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/cardiovascular-medicine/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="cardiovascular medicine" />
<meta property="og:description" content="Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification
Authors: Climente-Gonzalez, H.; Oh, M.; Chajewska, U.; Hosseini, R.; Mukherjee, S.; Gan, W.; Traylor, M.; Hu, S.; Fatemifar, G.; Del Villar, P. P.; Vernet, E.; Koelling, N.; Du, L.; Abraham, R.; Li, C.; Howson, J. M. M.
Score: 6.5, Published: 2024-01-13 DOI: 10.1101/2024.01.12.24301213
Cardiovascular diseases (CVD), primarily coronary heart disease and stroke, rank amongst the leading causes of long-term disability and mortality." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/cardiovascular-medicine/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-17T10:40:22+00:00" />
<meta property="article:modified_time" content="2024-01-17T10:40:22+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="cardiovascular medicine"/>
<meta name="twitter:description" content="Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification
Authors: Climente-Gonzalez, H.; Oh, M.; Chajewska, U.; Hosseini, R.; Mukherjee, S.; Gan, W.; Traylor, M.; Hu, S.; Fatemifar, G.; Del Villar, P. P.; Vernet, E.; Koelling, N.; Du, L.; Abraham, R.; Li, C.; Howson, J. M. M.
Score: 6.5, Published: 2024-01-13 DOI: 10.1101/2024.01.12.24301213
Cardiovascular diseases (CVD), primarily coronary heart disease and stroke, rank amongst the leading causes of long-term disability and mortality."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "cardiovascular medicine",
      "item": "https://trxiv.yorks0n.com/posts/cardiovascular-medicine/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "cardiovascular medicine",
  "name": "cardiovascular medicine",
  "description": "Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification\nAuthors: Climente-Gonzalez, H.; Oh, M.; Chajewska, U.; Hosseini, R.; Mukherjee, S.; Gan, W.; Traylor, M.; Hu, S.; Fatemifar, G.; Del Villar, P. P.; Vernet, E.; Koelling, N.; Du, L.; Abraham, R.; Li, C.; Howson, J. M. M.\nScore: 6.5, Published: 2024-01-13 DOI: 10.1101/2024.01.12.24301213\nCardiovascular diseases (CVD), primarily coronary heart disease and stroke, rank amongst the leading causes of long-term disability and mortality.",
  "keywords": [
    
  ],
  "articleBody": " Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification\nAuthors: Climente-Gonzalez, H.; Oh, M.; Chajewska, U.; Hosseini, R.; Mukherjee, S.; Gan, W.; Traylor, M.; Hu, S.; Fatemifar, G.; Del Villar, P. P.; Vernet, E.; Koelling, N.; Du, L.; Abraham, R.; Li, C.; Howson, J. M. M.\nScore: 6.5, Published: 2024-01-13 DOI: 10.1101/2024.01.12.24301213\nCardiovascular diseases (CVD), primarily coronary heart disease and stroke, rank amongst the leading causes of long-term disability and mortality. Providing accurate disease risk predictions and identifying genes associated with CVD are crucial for prevention, early intervention, and the development of novel medications. The recent availability of UK Biobank Proteomics data enables the investigation of the blood proteome and its association with a wide variety of diseases. We employed the Explainable Boosting Machine (EBM), an interpretable machine learning model, for CVD risk prediction. The EBM model using proteomics outperforms traditional clinical models with an AUROC of 0.767 and an AUPRC of 0.2405. Adding clinical features further improves the AUROC to 0.785 and the AUPRC to 0.2835. Our models demonstrate consistent performance across sexes and ethnicities. While most prior studies using proteomics data for disease prediction have primarily focused on maximizing the accuracy at the population level, our model provides additional enriched insights into individualized disease risk predictions and in-depth biological insights into biomarkers. Our analysis also uncovers nonlinear risks linked to varying feature values. We further corroborate our findings using statistical approaches and evidence from the literature. In conclusion, we present a highly accurate and explanatory framework for proteomics data analysis, offering comprehensive and in-depth molecular and clinical insights. Our findings support future approaches that prioritize individualized disease risk prediction and the identification of target genes for drug development.\nPredictors of blood pressure control and antihypertensive drug adherence among hypertensive patients: Hospital-based cross-sectional study\nAuthors: Elias, T. P.; Minyilshewa, A. T.; Tekle, M. A.; Gebreamlak, T. W.; Adde, B. L.\nScore: 1.4, Published: 2024-01-12 DOI: 10.1101/2024.01.11.24301173\nBackgroundHypertension or elevated blood pressure is a serious medical condition that significantly increases the risk of diseases of the heart, brain, kidneys, and other organs. Antihypertensive drug adherence is a key to controlling blood pressure. ObjectiveTo assess factors associated with antihypertensive drug adherence and blood pressurecontrol among hypertensive patients in Selected Public Hospitals under Addis Ababa City Administration. MethodA hospital-based cross-sectional study was conducted among hypertensive patients on follow-up in randomly selected Public Hospitals under the Addis Ababa City Administration from May 1, 2022, to August 31, 2022. The study population was 393 and patients who fulfilled the eligibility criteria were selected by systematic random sampling and the first participant was selected randomly. Data collection was conducted by reviewing the patients electronic medical records and by interviewing patients with a structured questionnaire. Data was entered into Epi-Info 7.2.1 and exported to SPSS version 25 software for analysis. Logistic regression analysis was done to see the association between the dependent and independent variables. ResultThe rate of antihypertensive drug adherence and blood pressure control was 72.5 % and 23.4% respectively. Participants with uncontrolled blood pressure were found to be 41.7% less adherent than those with controlled blood pressure (AOR= 0.59; 95% CI, 0.36-0.97). Non-adherence to dietary restriction (AOR, 3.31; 95% CI, 1.84-5.96) and chronic kidney disease (AOR=3.85; 95% CI, 1.41-10.52) are associated with good adherence, whereas using single antihypertensive drug (AOR=0.53; 95% CI, 0.30-0.94), and non-adherence to moderate physical exercise (AOR=0.30; 95% CI, 0.20-0.65) were associated with poor adherence to antihypertensive medications. Male sex (AOR=1.95; 95% CI, 1.04-3.28) and blood pressure measurement at home (AOR=0.59; 95% CI,0.36- 0.99) were independent predictors of controlled blood pressure. Drinking alcohol (AOR=1.92; 95% CI, 1.05-3.49) is inversely associated with blood pressure control. ConclusionDespite good adherence to antihypertensive medications, blood pressure control was low. This signifies the importance of lifestyle measures beyond pharmacologic intervention.\n",
  "wordCount" : "629",
  "inLanguage": "en",
  "datePublished": "2024-01-17T10:40:22Z",
  "dateModified": "2024-01-17T10:40:22Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/cardiovascular-medicine/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      cardiovascular medicine
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 17, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.12.24301213">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.12.24301213" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.12.24301213">
        <p class="paperTitle">Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.12.24301213" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.12.24301213" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Climente-Gonzalez, H.; Oh, M.; Chajewska, U.; Hosseini, R.; Mukherjee, S.; Gan, W.; Traylor, M.; Hu, S.; Fatemifar, G.; Del Villar, P. P.; Vernet, E.; Koelling, N.; Du, L.; Abraham, R.; Li, C.; Howson, J. M. M.</p>
        <p class="info">Score: 6.5, Published: 2024-01-13 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.12.24301213' target='https://doi.org/10.1101/2024.01.12.24301213'> 10.1101/2024.01.12.24301213</a></p>
        <p class="abstract">Cardiovascular diseases (CVD), primarily coronary heart disease and stroke, rank amongst the leading causes of long-term disability and mortality. Providing accurate disease risk predictions and identifying genes associated with CVD are crucial for prevention, early intervention, and the development of novel medications.

The recent availability of UK Biobank Proteomics data enables the investigation of the blood proteome and its association with a wide variety of diseases. We employed the Explainable Boosting Machine (EBM), an interpretable machine learning model, for CVD risk prediction. The EBM model using proteomics outperforms traditional clinical models with an AUROC of 0.767 and an AUPRC of 0.2405. Adding clinical features further improves the AUROC to 0.785 and the AUPRC to 0.2835. Our models demonstrate consistent performance across sexes and ethnicities.

While most prior studies using proteomics data for disease prediction have primarily focused on maximizing the accuracy at the population level, our model provides additional enriched insights into individualized disease risk predictions and in-depth biological insights into biomarkers. Our analysis also uncovers nonlinear risks linked to varying feature values. We further corroborate our findings using statistical approaches and evidence from the literature.

In conclusion, we present a highly accurate and explanatory framework for proteomics data analysis, offering comprehensive and in-depth molecular and clinical insights. Our findings support future approaches that prioritize individualized disease risk prediction and the identification of target genes for drug development.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.11.24301173">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.11.24301173" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.11.24301173">
        <p class="paperTitle">Predictors of blood pressure control and antihypertensive drug adherence among hypertensive patients: Hospital-based cross-sectional study</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.11.24301173" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.11.24301173" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Elias, T. P.; Minyilshewa, A. T.; Tekle, M. A.; Gebreamlak, T. W.; Adde, B. L.</p>
        <p class="info">Score: 1.4, Published: 2024-01-12 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.11.24301173' target='https://doi.org/10.1101/2024.01.11.24301173'> 10.1101/2024.01.11.24301173</a></p>
        <p class="abstract">BackgroundHypertension or elevated blood pressure is a serious medical condition that significantly increases the risk of diseases of the heart, brain, kidneys, and other organs. Antihypertensive drug adherence is a key to controlling blood pressure.

ObjectiveTo assess factors associated with antihypertensive drug adherence and blood pressurecontrol among hypertensive patients in Selected Public Hospitals under Addis Ababa City Administration.

MethodA hospital-based cross-sectional study was conducted among hypertensive patients on follow-up in randomly selected Public Hospitals under the Addis Ababa City Administration from May 1, 2022, to August 31, 2022. The study population was 393 and patients who fulfilled the eligibility criteria were selected by systematic random sampling and the first participant was selected randomly. Data collection was conducted by reviewing the patients electronic medical records and by interviewing patients with a structured questionnaire. Data was entered into Epi-Info 7.2.1 and exported to SPSS version 25 software for analysis. Logistic regression analysis was done to see the association between the dependent and independent variables.

ResultThe rate of antihypertensive drug adherence and blood pressure control was 72.5 % and 23.4% respectively. Participants with uncontrolled blood pressure were found to be 41.7% less adherent than those with controlled blood pressure (AOR= 0.59; 95% CI, 0.36-0.97). Non-adherence to dietary restriction (AOR, 3.31; 95% CI, 1.84-5.96) and chronic kidney disease (AOR=3.85; 95% CI, 1.41-10.52) are associated with good adherence, whereas using single antihypertensive drug (AOR=0.53; 95% CI, 0.30-0.94), and non-adherence to moderate physical exercise (AOR=0.30; 95% CI, 0.20-0.65) were associated with poor adherence to antihypertensive medications. Male sex (AOR=1.95; 95% CI, 1.04-3.28) and blood pressure measurement at home (AOR=0.59; 95% CI,0.36- 0.99) were independent predictors of controlled blood pressure. Drinking alcohol (AOR=1.92; 95% CI, 1.05-3.49) is inversely associated with blood pressure control.

ConclusionDespite good adherence to antihypertensive medications, blood pressure control was low. This signifies the importance of lifestyle measures beyond pharmacologic intervention.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
